Latest News and Press Releases
Want to stay updated on the latest news?
-
1Q26 Total Revenue of ~$71M Delivers ~45% Year-over-Year Growth 2Q26 Revenue Guidance of $86M to $88M and FY26 of $350M to $370M 40% Confirmed Objective Response Rate in Metastatic Serous...
-
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today...
-
Americold’s JV with EQT strengthens its balance sheet and expands flexibility to invest, supporting long‑term growth across its cold chain network.
-
Americold Announces First Quarter 2026 Results
-
Radware annunces Q1 2026 financial Results
-
LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- StepStone Group (Nasdaq: STEP), a leading global private markets investment firm, today announced it has joined LSEG’s Digital Markets Infrastructure (DMI)...
-
Angelini Pharma has entered into a definitive agreement to acquire Catalyst Pharmaceuticals.
-
Suominen Corporation’s Interim Report for January 1 – March 31, 2026
-
Kenmare Resources plc(“Kenmare” or the “Company” or the “Group”) 7 May 2026 Report on Payments to Governments Kenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers of...
-
Pharming today announced presentations at the 2026 Annual Meeting of the Clinical Immunology Society (CIS) in New Orleans, LA.